Paying users zone. Data is hidden behind: .
Get 1-month access to Gilead Sciences Inc. for $17.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Common-Size Income Statement
Gilead Sciences Inc., common-size consolidated income statement
|Income statement item||Description||The company|
|Income from operations||The net result for the period of deducting operating expenses from operating revenues.||Gilead Sciences Inc.’s income from operations as a percentage of product sales decreased from 2017 to 2018 and from 2018 to 2019.|
|Income before provision for income taxes||Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.||Gilead Sciences Inc.’s income before provision for income taxes as a percentage of product sales decreased from 2017 to 2018 and from 2018 to 2019.|
|Net income attributable to Gilead||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Gilead Sciences Inc.’s net income attributable to Gilead as a percentage of product sales increased from 2017 to 2018 but then slightly decreased from 2018 to 2019.|